These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 20505319

  • 1. miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo.
    Hu G, Chen D, Li X, Yang K, Wang H, Wu W.
    Cancer Biol Ther; 2010 Jul 15; 10(2):190-7. PubMed ID: 20505319
    [Abstract] [Full Text] [Related]

  • 2. miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.
    Duan FT, Qian F, Fang K, Lin KY, Wang WT, Chen YQ.
    Mol Cancer; 2013 Dec 13; 12():164. PubMed ID: 24330809
    [Abstract] [Full Text] [Related]

  • 3. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
    Li Z, Liu J, Chen H, Zhang Y, Shi H, Huang L, Tao J, Shen R, Wang T.
    Carcinogenesis; 2020 Jun 17; 41(4):467-477. PubMed ID: 31675755
    [Abstract] [Full Text] [Related]

  • 4. MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells.
    Xiang KM, Li XR.
    Asian Pac J Cancer Prev; 2014 Jun 17; 15(8):3767-72. PubMed ID: 24870791
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2.
    Ren XL, He GY, Li XM, Men H, Yi LZ, Lu GF, Xin SN, Wu PX, Li YL, Liao WT, Ding YQ, Liang L.
    J Cancer Res Clin Oncol; 2016 Mar 17; 142(3):581-92. PubMed ID: 26515696
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B.
    Gastroenterology; 2012 Sep 17; 143(3):811-820.e15. PubMed ID: 22641068
    [Abstract] [Full Text] [Related]

  • 7. Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met.
    Chen T, Cai SL, Li J, Qi ZP, Li XQ, Ye LC, Xie XF, Hou YY, Yao LQ, Xu MD, Zhou PH, Xu JM, Zhong YS.
    Sci Rep; 2017 Mar 14; 7():44543. PubMed ID: 28291253
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
    Sun C, Liu Z, Li S, Yang C, Xue R, Xi Y, Wang L, Wang S, He Q, Huang J, Xie S, Jiang W, Li D.
    Oncotarget; 2015 Sep 22; 6(28):25533-74. PubMed ID: 26325180
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y, Tang Q, Li M, Jiang S, Wang X.
    Biochem Biophys Res Commun; 2014 Feb 07; 444(2):199-204. PubMed ID: 24440701
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Zhao D, Sui Y, Zheng X.
    Oncol Rep; 2016 Feb 07; 35(2):1075-82. PubMed ID: 26718987
    [Abstract] [Full Text] [Related]

  • 13. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC).
    Zhang T, Cai X, Li Q, Xue P, Chen Z, Dong X, Xue Y.
    Oncotarget; 2016 Jul 05; 7(27):42225-42240. PubMed ID: 27302926
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
    Tian Z, Jiang H, Liu Y, Huang Y, Xiong X, Wu H, Dai X.
    Exp Cell Res; 2016 May 01; 343(2):135-147. PubMed ID: 27090017
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3.
    Li B, Xie Z, Li B.
    Tumour Biol; 2016 Aug 01; 37(8):10075-84. PubMed ID: 26820128
    [Abstract] [Full Text] [Related]

  • 17. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J.
    Oncogene; 2013 Oct 17; 32(42):5078-88. PubMed ID: 23208495
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
    Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST, Ghoshal K.
    J Biol Chem; 2008 Nov 28; 283(48):33394-405. PubMed ID: 18818206
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C, Lin Y, Mao Y, Huang Z, Liu AY, Ma H, Yu D, Maitikabili A, Xiao H, Zhang C, Liu F, Luo Q, Ouyang G.
    Oncotarget; 2016 Apr 19; 7(16):21825-39. PubMed ID: 26968810
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.
    Guo ST, Jiang CC, Wang GP, Li YP, Wang CY, Guo XY, Yang RH, Feng Y, Wang FH, Tseng HY, Thorne RF, Jin L, Zhang XD.
    Oncogene; 2013 Apr 11; 32(15):1910-20. PubMed ID: 22710713
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.